期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Treatment of 60 Cases of Gouty Arthritis with Modified Simiao Tang 被引量:5
1
作者 邱仁斌 沈瑞子 +3 位作者 林德就 陈远林 叶红萍 朱函亭(译) 《Journal of Traditional Chinese Medicine》 SCIE CAS CSCD 2008年第2期94-97,共4页
Objective:To observe the clinical effect of a modified Simiao Tang (加味四妙汤 Modified Decoction of Four Wonderful Drugs) for gouty arthritis and its influence on uric acid in blood. Methods: 120 cases of gouty arthr... Objective:To observe the clinical effect of a modified Simiao Tang (加味四妙汤 Modified Decoction of Four Wonderful Drugs) for gouty arthritis and its influence on uric acid in blood. Methods: 120 cases of gouty arthritis were randomly divided into the treatment group and control group with 60 cases in each group. Modified Simiao Tang (MST) was orally administered to the patients in the treatment group and allopurinol tablet was orally administered to the patients in the control group. The clinical effects of two groups were evaluated after one-week treatment and uric acid (UA) and C-reactive protein (CRP) levels in blood were determined after 1-month treatment. Results: The total effective rate in the treatment group was significantly higher than in the control group, 86.7% vs. 68.3% (P< 0.01). And the treatment group was also significantly better than the control group in decreasing UA and CRP (P<0.05 or P<0.01). Conclusions: MST can significantly improve the symptoms and signs of gouty arthritis and decrease the levels of UA and CRP. It is good for gouty arthritis. 展开更多
关键词 Gouty arthritis Uric acid Modified Simiao Tang (Modified Decoction of Four Wonderful drugs)
下载PDF
Coexisting ankylosing spondylitis and rheumatoid arthritis: A case report with literature review 被引量:7
2
作者 GUO Ying-ying YANG Li-li CUI Hua-dong ZHAO Shuai ZHANG Ning 《Chinese Medical Journal》 SCIE CAS CSCD 2011年第20期3430-3432,共3页
A 30-year-old female patient with coexisting ankylosing spondylitis and rheumatoid arthritis was diagnosed and treated. The human leukocyte antigen (HLA)-B27 is a predisposing factor of ankylosing spondylitis and HL... A 30-year-old female patient with coexisting ankylosing spondylitis and rheumatoid arthritis was diagnosed and treated. The human leukocyte antigen (HLA)-B27 is a predisposing factor of ankylosing spondylitis and HLA-DR4 is a predisposing factor of rheumatoid arthritis. This patient was HLA-B27 and HLA-DR4 positive, and ankylosing spondylitis manifested before rheumatoid arthritis. After disease modifying anti-rheumatic drugs successfully arrested ankylosing spondylitis activity the patient conceived and delivered a healthy baby. One year later, she developed peripheral polyarthritis and was diagnosed with rheumatoid arthritis. We hypothesized that pregnancy may be one of the environmental factors that can activate rheumatoid arthritis, and that disease modifying anti-rheumatic drugs play an important role in keeping the disease under control. 展开更多
关键词 ankylosing spondylitis disease modifying anti-rheumatic drugs rheumatoid arthritis
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部